AIM logo

AIM ImmunoTech (AIM) Current Assets

Annual Current Assets

$14.56 M
-$21.77 M-59.92%

31 December 2023

AIM Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$7.57 M
-$2.79 M-26.94%

30 September 2024

AIM Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AIM Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-59.9%-66.7%
3 y3 years-63.9%-80.1%
5 y5 years+283.1%-40.0%

AIM Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-71.0%at low-85.0%at low
5 y5 years-71.0%+283.1%-85.2%at low
alltimeall time-75.1%+315.3%-87.8%+298.4%

AIM ImmunoTech Current Assets History

DateAnnualQuarterly
Sept 2024
-
$7.57 M(-26.9%)
June 2024
-
$10.36 M(-8.4%)
Mar 2024
-
$11.31 M(-22.3%)
Dec 2023
$4.83 M(+15.8%)
$14.56 M(-36.0%)
Sept 2023
-
$22.74 M(-21.2%)
June 2023
-
$28.87 M(-12.9%)
Mar 2023
-
$33.16 M(-8.7%)
Dec 2022
$4.17 M(-44.3%)
$36.32 M(-11.7%)
Sept 2022
-
$41.15 M(-10.6%)
June 2022
-
$46.05 M(-8.6%)
Mar 2022
-
$50.38 M(+0.3%)
Dec 2021
$7.49 M(-69.2%)
$50.21 M(+32.0%)
Sept 2021
-
$38.04 M(-8.0%)
June 2021
-
$41.33 M(-19.3%)
Mar 2021
-
$51.22 M(+27.1%)
Dec 2020
$24.27 M(+135.5%)
$40.31 M(+1.4%)
Sept 2020
-
$39.76 M(+13.1%)
June 2020
-
$35.16 M(+18.4%)
Mar 2020
-
$29.71 M(+184.4%)
Dec 2019
$10.31 M(+2.6%)
$10.45 M(-17.2%)
Sept 2019
-
$12.62 M(+236.2%)
June 2019
-
$3.75 M(-35.9%)
Mar 2019
-
$5.86 M(+54.1%)
Dec 2018
$10.05 M(-6.1%)
$3.80 M(-23.1%)
Sept 2018
-
$4.94 M(-6.5%)
June 2018
-
$5.29 M(-6.7%)
Mar 2018
-
$5.66 M(+61.6%)
Dec 2017
$10.70 M(-10.3%)
$3.50 M(-6.2%)
Sept 2017
-
$3.73 M(-20.2%)
June 2017
-
$4.68 M(-9.8%)
Mar 2017
-
$5.19 M(-25.2%)
Dec 2016
$11.93 M(-2.5%)
$6.94 M(-25.6%)
Sept 2016
-
$9.33 M(-13.0%)
June 2016
-
$10.73 M(+12.5%)
Mar 2016
-
$9.54 M(-9.8%)
Dec 2015
$12.23 M(-5.4%)
$10.57 M(-24.4%)
Sept 2015
-
$13.98 M(-18.1%)
June 2015
-
$17.06 M(-4.8%)
Mar 2015
-
$17.92 M(+8.5%)
Dec 2014
$12.93 M(-2.9%)
$16.51 M(-6.6%)
Sept 2014
-
$17.67 M(-13.6%)
June 2014
-
$20.46 M(-6.5%)
Mar 2014
-
$21.89 M(+18.0%)
Dec 2013
$13.31 M(+2.7%)
$18.55 M(-37.2%)
Sept 2013
-
$29.55 M(-10.1%)
June 2013
-
$32.88 M(-14.8%)
Mar 2013
-
$38.58 M(-13.7%)
Dec 2012
$12.97 M(+10.6%)
$44.73 M(+22.7%)
Sept 2012
-
$36.45 M(+19.6%)
June 2012
-
$30.49 M(-9.4%)
Mar 2012
-
$33.64 M(+5.8%)
Dec 2011
$11.73 M(-21.9%)
$31.79 M(-7.1%)
Sept 2011
-
$34.22 M(+3.6%)
June 2011
-
$33.04 M(-9.9%)
Mar 2011
-
$36.67 M(0.0%)
Dec 2010
$15.01 M
$36.67 M(-4.9%)
Sept 2010
-
$38.56 M(+4.7%)
June 2010
-
$36.82 M(-31.8%)
DateAnnualQuarterly
Mar 2010
-
$53.99 M(-7.6%)
Dec 2009
$6.59 M(+11.7%)
$58.40 M(-5.9%)
Sept 2009
-
$62.07 M(+45.1%)
June 2009
-
$42.78 M(+540.5%)
Mar 2009
-
$6.68 M(-8.7%)
Dec 2008
$5.90 M(-9.9%)
$7.31 M(-18.8%)
Sept 2008
-
$9.01 M(-22.1%)
June 2008
-
$11.56 M(-17.9%)
Mar 2008
-
$14.09 M(-15.1%)
Dec 2007
$6.54 M(-20.1%)
$16.60 M(-14.0%)
Sept 2007
-
$19.30 M(-14.2%)
June 2007
-
$22.50 M(-14.1%)
Mar 2007
-
$26.20 M(+12.7%)
Dec 2006
$8.19 M(+27.1%)
$23.24 M(+13.5%)
Sept 2006
-
$20.48 M(-11.3%)
June 2006
-
$23.09 M(-10.5%)
Mar 2006
-
$25.79 M(+41.6%)
Dec 2005
$6.45 M(+7.4%)
$18.21 M(+32.9%)
Sept 2005
-
$13.70 M(-7.0%)
June 2005
-
$14.73 M(-12.3%)
Mar 2005
-
$16.79 M(-13.0%)
Dec 2004
$6.00 M(+25.1%)
$19.29 M(-9.4%)
Sept 2004
-
$21.28 M(+70.9%)
June 2004
-
$12.46 M(+19.3%)
Mar 2004
-
$10.44 M(+21.3%)
Dec 2003
$4.80 M(+190.6%)
$8.61 M(+6.8%)
Sept 2003
-
$8.06 M(+13.2%)
June 2003
-
$7.12 M(+3.2%)
Mar 2003
-
$6.90 M(+57.2%)
Dec 2002
$1.65 M(-48.9%)
$4.39 M(-0.7%)
Sept 2002
-
$4.42 M(-27.3%)
June 2002
-
$6.07 M(-19.3%)
Mar 2002
-
$7.53 M(-14.5%)
Dec 2001
$3.23 M(-19.7%)
$8.81 M(+98.7%)
Sept 2001
-
$4.43 M(-19.8%)
June 2001
-
$5.53 M(-17.7%)
Mar 2001
-
$6.72 M(-25.7%)
Dec 2000
$4.02 M(+27.0%)
$9.04 M(-4.3%)
Sept 2000
-
$9.46 M(-13.6%)
June 2000
-
$10.94 M(-11.4%)
Mar 2000
-
$12.35 M(+12.2%)
Dec 1999
$3.17 M(+21.8%)
$11.00 M(+39.2%)
Sept 1999
-
$7.90 M(-14.1%)
June 1999
-
$9.20 M(-17.9%)
Mar 1999
-
$11.20 M(-18.2%)
Dec 1998
$2.60 M(+85.7%)
$13.70 M(-11.6%)
Sept 1998
-
$15.50 M(+101.3%)
June 1998
-
$7.70 M(-12.5%)
Mar 1998
-
$8.80 M(-12.9%)
Dec 1997
$1.40 M(-12.5%)
$10.10 M(+431.6%)
Sept 1997
-
$1.90 M(-36.7%)
June 1997
-
$3.00 M(-28.6%)
Mar 1997
-
$4.20 M(-22.2%)
Dec 1996
$1.60 M(+23.1%)
$5.40 M(-20.6%)
Sept 1996
-
$6.80 M(+161.5%)
June 1996
-
$2.60 M(-29.7%)
Mar 1996
-
$3.70 M(-67.5%)
Dec 1995
$1.30 M
$11.40 M

FAQ

  • What is AIM ImmunoTech annual total current assets?
  • What is the all time high annual current assets for AIM ImmunoTech?
  • What is AIM ImmunoTech annual current assets year-on-year change?
  • What is AIM ImmunoTech quarterly total current assets?
  • What is the all time high quarterly current assets for AIM ImmunoTech?
  • What is AIM ImmunoTech quarterly current assets year-on-year change?

What is AIM ImmunoTech annual total current assets?

The current annual current assets of AIM is $14.56 M

What is the all time high annual current assets for AIM ImmunoTech?

AIM ImmunoTech all-time high annual total current assets is $58.40 M

What is AIM ImmunoTech annual current assets year-on-year change?

Over the past year, AIM annual total current assets has changed by -$21.77 M (-59.92%)

What is AIM ImmunoTech quarterly total current assets?

The current quarterly current assets of AIM is $7.57 M

What is the all time high quarterly current assets for AIM ImmunoTech?

AIM ImmunoTech all-time high quarterly total current assets is $62.07 M

What is AIM ImmunoTech quarterly current assets year-on-year change?

Over the past year, AIM quarterly total current assets has changed by -$15.17 M (-66.71%)